News
Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Perspective Therapeutics (CATX – Research Report) today and set a price target of $6.00. The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback